Cargando…

Rethinking thresholds for serological evidence of influenza virus infection

INTRODUCTION: For pathogens such as influenza that cause many subclinical cases, serologic data can be used to estimate attack rates and the severity of an epidemic in near real time. Current methods for analysing serologic data tend to rely on use of a simple threshold or comparison of titres betwe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xiahong, Siegel, Karen, Chen, Mark I‐Cheng, Cook, Alex R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410725/
https://www.ncbi.nlm.nih.gov/pubmed/28294578
http://dx.doi.org/10.1111/irv.12452
_version_ 1783232741513363456
author Zhao, Xiahong
Siegel, Karen
Chen, Mark I‐Cheng
Cook, Alex R.
author_facet Zhao, Xiahong
Siegel, Karen
Chen, Mark I‐Cheng
Cook, Alex R.
author_sort Zhao, Xiahong
collection PubMed
description INTRODUCTION: For pathogens such as influenza that cause many subclinical cases, serologic data can be used to estimate attack rates and the severity of an epidemic in near real time. Current methods for analysing serologic data tend to rely on use of a simple threshold or comparison of titres between pre‐ and post‐epidemic, which may not accurately reflect actual infection rates. METHODS: We propose a method for quantifying infection rates using paired sera and bivariate probit models to evaluate the accuracy of thresholds currently used for influenza epidemics with low and high existing herd immunity levels, and a subsequent non‐influenza period. Pre‐ and post‐epidemic sera were taken from a cohort of adults in Singapore (n=838). Bivariate probit models with latent titre levels were fit to the joint distribution of haemagglutination‐inhibition assay‐determined antibody titres using Markov chain Monte Carlo simulation. RESULTS: Estimated attack rates were 15% (95% credible interval: 12%‐19%) for the first H1N1 pandemic wave. For a large outbreak due to a new strain, a threshold of 1:20 and a twofold rise (if pared sera is available) would result in a more accurate estimate of incidence. CONCLUSION: The approach presented here offers the basis for a reconsideration of methods used to assess diagnostic tests by both reconsidering the thresholds used and by analysing serological data with a novel statistical model.
format Online
Article
Text
id pubmed-5410725
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-54107252017-05-03 Rethinking thresholds for serological evidence of influenza virus infection Zhao, Xiahong Siegel, Karen Chen, Mark I‐Cheng Cook, Alex R. Influenza Other Respir Viruses Original Articles INTRODUCTION: For pathogens such as influenza that cause many subclinical cases, serologic data can be used to estimate attack rates and the severity of an epidemic in near real time. Current methods for analysing serologic data tend to rely on use of a simple threshold or comparison of titres between pre‐ and post‐epidemic, which may not accurately reflect actual infection rates. METHODS: We propose a method for quantifying infection rates using paired sera and bivariate probit models to evaluate the accuracy of thresholds currently used for influenza epidemics with low and high existing herd immunity levels, and a subsequent non‐influenza period. Pre‐ and post‐epidemic sera were taken from a cohort of adults in Singapore (n=838). Bivariate probit models with latent titre levels were fit to the joint distribution of haemagglutination‐inhibition assay‐determined antibody titres using Markov chain Monte Carlo simulation. RESULTS: Estimated attack rates were 15% (95% credible interval: 12%‐19%) for the first H1N1 pandemic wave. For a large outbreak due to a new strain, a threshold of 1:20 and a twofold rise (if pared sera is available) would result in a more accurate estimate of incidence. CONCLUSION: The approach presented here offers the basis for a reconsideration of methods used to assess diagnostic tests by both reconsidering the thresholds used and by analysing serological data with a novel statistical model. John Wiley and Sons Inc. 2017-04-26 2017-05 /pmc/articles/PMC5410725/ /pubmed/28294578 http://dx.doi.org/10.1111/irv.12452 Text en © 2017 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhao, Xiahong
Siegel, Karen
Chen, Mark I‐Cheng
Cook, Alex R.
Rethinking thresholds for serological evidence of influenza virus infection
title Rethinking thresholds for serological evidence of influenza virus infection
title_full Rethinking thresholds for serological evidence of influenza virus infection
title_fullStr Rethinking thresholds for serological evidence of influenza virus infection
title_full_unstemmed Rethinking thresholds for serological evidence of influenza virus infection
title_short Rethinking thresholds for serological evidence of influenza virus infection
title_sort rethinking thresholds for serological evidence of influenza virus infection
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410725/
https://www.ncbi.nlm.nih.gov/pubmed/28294578
http://dx.doi.org/10.1111/irv.12452
work_keys_str_mv AT zhaoxiahong rethinkingthresholdsforserologicalevidenceofinfluenzavirusinfection
AT siegelkaren rethinkingthresholdsforserologicalevidenceofinfluenzavirusinfection
AT chenmarkicheng rethinkingthresholdsforserologicalevidenceofinfluenzavirusinfection
AT cookalexr rethinkingthresholdsforserologicalevidenceofinfluenzavirusinfection